Biktarvy, formally known as bictegravir, represents a potent single-tablet regimen for treating HIV infection. This formula integrates three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by preventing the the viral ability to copy within the body, remarkably lowering the viral load. For many individ